Impact of Adherence to Antihypertensive Agents on Clinical Outcomes and Hospitalization Costs

Abstract

Low adherence to AH agents is correlated with a higher risk of vascular events, hospitalization, and greater healthcare costs. An increased level of adherence to AH agents should provide a better health status for individuals and a net economic gain.